On October 9, 2023, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd closed the transaction. The company amended the terms of the transaction and issued 935,2740 A shares at a price of CNY 32.29 per share for the gross proceeds of CNY 301,999,975. The net proceeds will be CNY 294,836,293 after the issuance expense of CNY 7,163,682.37.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Equities
002864
CNE1000032C9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.57 CNY | -1.60% | -1.27% | -23.17% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.17% | 431M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 002864 Stock
- News Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
- Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announced that it has received CNY 301.999975 million in funding